Prevention of polyarthritis in human TNF transgenic mice by D2E7:: A fully human anti-human TNF monoclonal antibody.

被引：0
|
作者：
Kaymakçalan, Z
Haralambous, S
Tracey, D
Kamen, R
Salfeld, J
Kollias, G
机构：
[1] BASF Biores Corp, Worcester, MA USA
[2] Hellen Pasteur Inst, Athens, Greece
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
390
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] Generation of fully human anti-TNF antibody D2E7
    Salfield, J
    Kaymakçalan, J
    Tracey, D
    Roberts, A
    Kamen, R
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S57 - S57
  • [2] Pharmacokinetics of the fully human anti-TNF-α monoclonal antibody adalimumab (D2E7) in the non-human primate.
    Bankmann, Y
    Buehler, V
    Kaymakçalan, Z
    Lassmann, A
    Salfeld, J
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S72 - S72
  • [3] Preliminary results of early clinical trials with the fully human anti-TNFα monoclonal antibody D2E7
    Kempeni, J
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 70 - 72
  • [4] Efficacy of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.
    van de Putte, BA
    Rau, R
    Breedveld, FC
    Kalden, JR
    Malaise, MG
    Schattenkirchner, M
    Emery, P
    Burmester, GR
    Zeidler, H
    Moutsopoulos, HH
    Compagnone, D
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S400 - S400
  • [5] One year efficacy results of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.
    van de Putte, LBA
    Rau, R
    Breedveld, FC
    Kalden, JR
    Malaise, MG
    Schattenkirchner, M
    Emery, P
    Burmester, GR
    Zeidler, H
    Dressler, R
    Compagnone, D
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S269 - S269
  • [6] In vitro and in vivo comparison of adalimumab (D2E7), a fully human Anti-TNF-α monoclonal antibody, expressed in transfected CHO cells versus transgenic goats.
    Kaymakçalan, Z
    Sakorafas, P
    Xiong, L
    Beam, C
    Kalghatgi, L
    Stanley, K
    Avgerinos, G
    Salfeld, J
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S103 - S103
  • [7] Update on D2E7:: a fully human anti-tumour necrosis factor α monoclonal antibody
    Kempeni, J
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 : 44 - 45
  • [8] Improvement in health utility among rheumatoid arthritis (RA) patients treated with adalimumab (D2E7),a fully human anti-TNF monoclonal antibody
    van de Putte, L
    Boggs, R
    Sengupta, N
    Dietz, B
    Bergemann, R
    Rosery, H
    Kupper, H
    VALUE IN HEALTH, 2002, 5 (06) : 461 - 461
  • [9] The effect of D2E7, a new human anti-TNFα monoclonal antibody, on the oxidative burst of PMN in patients with RA.
    den Broeder, AA
    Wanten, GJA
    van Riel, PLCM
    Kroot, EJ
    Naber, THJ
    Barrera, P
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S57 - S57
  • [10] Pharmacokinetics of adalimumab (D2E7), a fully human anti-TNF-α monoclonal antibody, following a single intravenous injection in rheumatoid arthritis patients treated with methotrexate
    Velagapudi, RB
    Noertershauser, P
    Bankmann, Y
    Granneman, RG
    Awni, W
    Chartash, E
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S133 - S133
12345